Iodoacetamide structure
|
Common Name | Iodoacetamide | ||
---|---|---|---|---|
CAS Number | 144-48-9 | Molecular Weight | 184.964 | |
Density | 2.3±0.1 g/cm3 | Boiling Point | 297.1±23.0 °C at 760 mmHg | |
Molecular Formula | C2H4INO | Melting Point | 92-95 °C(lit.) | |
MSDS | Chinese USA | Flash Point | 133.5±22.6 °C | |
Symbol |
GHS06, GHS08 |
Signal Word | Danger |
Use of Iodoacetamide2-Iodoacetamide (Iodoacetamide), an alkylating agent, is a commonly used agent for alkylation of cysteine during sample preparation for proteomics[1][2]. |
Name | 2-Iodoacetamide |
---|---|
Synonym | More Synonyms |
Description | 2-Iodoacetamide (Iodoacetamide), an alkylating agent, is a commonly used agent for alkylation of cysteine during sample preparation for proteomics[1][2]. |
---|---|
Related Catalog | |
In Vivo | 2-Iodoacetamide (2.0-10 mg; drinking; daily; 20-93 days) feeding always produces chronic deep ulcers in the secretory part of the rat stomach[2]. Animal Model: Sprague-Dawley rats[2] Dosage: 2.0-10 mg Administration: Drinking water, daily, for periods of 20 to 93 days Result: Produced gastritis which was further complicated by chronic ulceration in many of the test rats. |
References |
[2]. J J LALICH. Iodoacetamide induced gastric ulcers in rats. Proc Soc Exp Biol Med. 1962 Apr;109:905-8. |
Density | 2.3±0.1 g/cm3 |
---|---|
Boiling Point | 297.1±23.0 °C at 760 mmHg |
Melting Point | 92-95 °C(lit.) |
Molecular Formula | C2H4INO |
Molecular Weight | 184.964 |
Flash Point | 133.5±22.6 °C |
Exact Mass | 184.933746 |
PSA | 43.09000 |
LogP | -0.19 |
Vapour Pressure | 0.0±0.6 mmHg at 25°C |
Index of Refraction | 1.602 |
Storage condition | 2-8°C |
Stability | Stable, but light sensitive. Incompatible with strong oxidizing agents, strong bases, reducing agents, acids. |
Water Solubility | slightly soluble |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
Symbol |
GHS06, GHS08 |
---|---|
Signal Word | Danger |
Hazard Statements | H301-H317-H334-H413 |
Precautionary Statements | P261-P280-P301 + P310-P342 + P311 |
Personal Protective Equipment | Eyeshields;Faceshields;Gloves;type P2 (EN 143) respirator cartridges |
Hazard Codes | T:Toxic; |
Risk Phrases | R25;R36/37/38;R43 |
Safety Phrases | S22-S36/37-S45-S37/39-S26-S24 |
RIDADR | UN 2811 6.1/PG 3 |
WGK Germany | 3 |
RTECS | AC4200000 |
Packaging Group | III |
Hazard Class | 6.1 |
HS Code | 2924199090 |
~66% Iodoacetamide CAS#:144-48-9 |
Literature: Molecular Probes, Inc. Patent: US5274113 A1, 1993 ; |
~% Iodoacetamide CAS#:144-48-9 |
Literature: Zeitschrift fuer Physikalische Chemie, Abteilung A: Chemische Thermodynamik, Kinetik, Elektrochemie, Eigenschaftslehre, , vol. 157, p. 249,254 Zeitschrift fuer Physikalische Chemie, Abteilung A: Chemische Thermodynamik, Kinetik, Elektrochemie, Eigenschaftslehre, , vol. 163, p. 38 |
~% Iodoacetamide CAS#:144-48-9 |
Literature: Synthesis, , p. 574 - 575 |
~% Iodoacetamide CAS#:144-48-9 |
Literature: Chemische Berichte, , vol. 41, p. 2117 Chemische Berichte, , vol. 42, p. 2056 |
Precursor 4 | |
---|---|
DownStream 10 | |
HS Code | 2924199090 |
---|---|
Summary | 2924199090. other acyclic amides (including acyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
A new enabling proteomics methodology to investigate membrane associated proteins from parasitic nematodes: case study using ivermectin resistant and ivermectin susceptible isolates of Caenorhabditis elegans and Haemonchus contortus.
Vet. Parasitol. 207(3-4) , 266-75, (2015) The mechanisms involved in anthelmintic resistance (AR) are complex but a greater understanding of AR management is essential for effective and sustainable control of parasitic helminth worms in lives... |
|
Rad23 interaction with the proteasome is regulated by phosphorylation of its ubiquitin-like (UbL) domain.
J. Mol. Biol. 426(24) , 4049-60, (2014) Rad23 was identified as a DNA repair protein, although a role in protein degradation has been described. The protein degradation function of Rad23 contributes to cell cycle progression, stress respons... |
|
Proteomic analysis of nasal epithelial cells from cystic fibrosis patients.
PLoS ONE 9(9) , e108671, (2014) The pathophysiology of cystic fibrosis (CF) lung disease remains incompletely understood. New explanations for the pathogenesis of CF lung disease may be discovered by studying the patterns of protein... |
MFCD00008028 |
carbamoylmethyl iodide |
2-Iodo-acetamide |
USAF D-1 |
Monoiodoacetamide |
2-iodoacetamido |
Acetamide, 2-iodo- |
Iodoacetamide |
ACETAMIDE,2-IODO |
2-Iodoacetamide |
Surauto |
EINECS 205-630-1 |